NFKB1 and non-small cell lung carcinoma: Proteasome inhibition, which blocks the degradation of inhibitor of κB (IκB) protein, thus blocking NF-κB nuclear translocation and activation, also sensitized NSCLC cells to apoptosis [21,22].